Clinical trials
Recruiting Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| University Hospital, Clermont-Ferrand | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Enliven Therapeutics | 1 |
| Poitiers University Hospital | 1 |
| Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| University Hospital, Bordeaux | 1 |
| Versailles Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 13 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Leukemia | 2 |
| Blast Crisis | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, Myeloid | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.